Literature DB >> 24016166

Cost analyses approaches in medical education: there are no simple solutions.

Kieran Walsh1, Henry Levin, Peter Jaye, James Gazzard.   

Abstract

CONTEXT: Medical education is expensive. Although we have made progress in working out 'what works' in medical education, there are few data on whether medical education offers value relative to cost. Research into cost and value in medical education is beset by problems. One of the major problems is the lack of clear definitions for many of the terms commonly used. Phrases such as cost-effectiveness analysis, cost-benefit analysis, cost-utility analysis and cost-feasibility analysis are used without authors explaining to readers what they mean (and sometimes without authors themselves understanding what they mean). Sometimes such terms are used interchangeably and sometimes they are used as rhetorical devices without any real evidence that backs up such rhetoric as to the cost-effectiveness or otherwise of educational interventions. The frequent misuse of these terms is surprising considering the importance of the topics under consideration and the need for precision in many aspects of medical education.
METHODS: Here we define commonly used terms in cost analyses and give examples of their usage in the context of medical education.
CONCLUSIONS: Cost-effectiveness analysis refers to the evaluation of two or more alternative educational approaches or interventions according to their costs and their effects in producing a certain outcome. Cost-benefit analysis refers to 'the evaluation of alternatives according to their costs and benefits when each is measured in monetary terms'. Cost-utility analysis is the examination of two or more alternatives according to their cost and their utility. In this context, utility means the satisfaction among individuals as a result of one or more outcome or the perceived value of the expected outcomes to a particular constituency. Cost-feasibility analysis involves simply measuring the cost of a proposed intervention in order to decide whether it is feasible.
© 2013 John Wiley & Sons Ltd.

Mesh:

Year:  2013        PMID: 24016166     DOI: 10.1111/medu.12214

Source DB:  PubMed          Journal:  Med Educ        ISSN: 0308-0110            Impact factor:   6.251


  22 in total

1.  Continuing medical education: The perspective of quality improvement.

Authors:  Kieran Walsh
Journal:  Can Urol Assoc J       Date:  2014 Jan-Feb       Impact factor: 1.862

2.  The professional practice of registered nurses.

Authors:  Kieran Walsh
Journal:  Perm J       Date:  2014

3.  Cost-benefit analysis of healthcare professional education: report of a conference workshop.

Authors:  Kieran Walsh; Cindy Noben; Simon Gregory; Wee Shiong Lim; Chris Green; Trudie Roberts; Stephen Maloney; Dragan Ilic; George Rivers; Scott Reeves
Journal:  BMJ Simul Technol Enhanc Learn       Date:  2018-03-23

4.  Medical Students' Experiences of Unplanned Leaves of Absence.

Authors:  Robert Fallar; John Leikauf; Olanrewaju Dokun; Shashi Anand; Peter Gliatto; Lisa Mellman; Stephanie Autenrieth; Craig Katz
Journal:  Med Sci Educ       Date:  2019-08-07

5.  Cost-Effectiveness Analysis in Performance Assessments: A Case Study of the Objective Structured Clinical Examination.

Authors:  Zhehan Jiang; Jinying Ouyang; Li Li; Yuting Han; Lingling Xu; Ren Liu; Junhua Sun
Journal:  Med Educ Online       Date:  2022-12

6.  Anatomical sketching and education: The next steps.

Authors:  Kieran Walsh
Journal:  J Educ Health Promot       Date:  2015-08-06

7.  Willingness to pay in medical education.

Authors:  Kieran Walsh
Journal:  J Biomed Res       Date:  2014-03-15

8.  Commentary: simulations in breast cancer: the next steps.

Authors:  Kieran Walsh
Journal:  J Breast Cancer       Date:  2014-09-30       Impact factor: 3.588

9.  Funding sources for continuing medical education: A different perspective.

Authors:  Kieran Walsh
Journal:  Indian J Crit Care Med       Date:  2014-11

10.  Self-medication among medical students: What strategies could help?

Authors:  Kieran Walsh
Journal:  J Res Pharm Pract       Date:  2014-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.